LOGIN
ID
PW
MemberShip
2025-07-04 10:44
All News
Policy
Company
Product
Opinion
InterView
°Ë»ö
Dailypharm Live Search
Close
Roche 2018 Annualreport
Roche 2018 Annualreport
2019-12-23
NOVARTIS 2018 Annualreport
NOVARTIS 2018 Annualreport
2019-12-23
2018 Multinational Pharma Sales
2018 Multinational Pharma Sales
2019-11-15
Risk-Sharing Agreements in the EU: A Systematic Review
Risk-Sharing Agreements in the EU: A Systematic Review of Major Trends
2019-11-15
Managed Entry Agreements for
Managed Entry Agreements for Oncology Drugs
2019-11-15
OPINION
[Reporter¡¯s View] NHI finances and reimb expansions
Reporter's view |
Lee, Jeong-Hwan
[Reporter¡¯s View] Doctors agree Korea¡¯s reimb is too slow
Reporter's view |
Eo, Yun-Ho
[Reporter's View] Divisional restructuring needed
Reporter's view |
Lee, Hye-Kyung
INTERVIEW
'Viatris will lead market with innovation and leadership'
Bill Schuster, Representative Director & Country Manager of Viatris Korea
"Livtencity offers new CMV trt for transplant patients"
Dr. Sang-Oh Lee, professor at Seoul Asan Medical Center's Department of Infectious Diseases
¡®SGLT2i+TZD promising for diabetics with fatty liver risk¡¯
Cheol-Young Park, Professor of Endocrinology at Kangbuk Samsung Hospital
Hemlibra shows long-term efficacy and safety in hemophilia
Long-term prevention of bleeding episodes
"High hopes for reimbursed Ilaris¡¦a new treatment option"
Dr. Soyoung Lee, Professor of Pediatric & Adolescent Medicine at Hallym University Sacred Heart Hospital
Data
Roche 2018 Annualreport
Roche 2018 Annualreport
NOVARTIS 2018 Annualreport
NOVARTIS 2018 Annualreport
2018 Multinational Pharma Sales
2018 Multinational Pharma Sales
MOST READ
1
K-CAB¡¤Entresto awaiting the Supreme Court rulings
2
Dong-A ST-Ipsen to comarket prostate cancer drug Diphereline
3
Leclaza combination therapy takes over Europe
4
AstraZeneca Korea launches ¡®Lung Health Checkbus¡¯ campaign
5
Metabolic disease drug development landscape evolves
6
Pressures to reform Korea's drug pricing system
7
[Reporter¡¯s View] Doctors agree Korea¡¯s reimb is too slow
8
Pharma tries to flip the returned out-licensing of new drugs
9
Will twice-yearly Bayer's 'Eylea' become available in KOR?
10
Lilly launches Ebglyss in Korea¡¦ sparks competition